Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India

Objective. The increased use of antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV, adversely leading to the emergence of HIV drug resistance (HIVDR). In this study we aim to evaluate the prevalence of HIVDR mutations in ART-naive HIV-1 infected patients from no...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Sinha, H. Ahmad, R. C. Shekhar, N. Kumar, L. Dar, J. C. Samantaray, S. K. Sharma, A. Bhargava, R. M. Pandey, R. L. Mitsuyasu, J. L. Fahey
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2012/905823
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552162442346496
author S. Sinha
H. Ahmad
R. C. Shekhar
N. Kumar
L. Dar
J. C. Samantaray
S. K. Sharma
A. Bhargava
R. M. Pandey
R. L. Mitsuyasu
J. L. Fahey
author_facet S. Sinha
H. Ahmad
R. C. Shekhar
N. Kumar
L. Dar
J. C. Samantaray
S. K. Sharma
A. Bhargava
R. M. Pandey
R. L. Mitsuyasu
J. L. Fahey
author_sort S. Sinha
collection DOAJ
description Objective. The increased use of antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV, adversely leading to the emergence of HIV drug resistance (HIVDR). In this study we aim to evaluate the prevalence of HIVDR mutations in ART-naive HIV-1 infected patients from northern India. Design. Analysis was performed using Viroseq genotyping system based on sequencing of entire protease and two-thirds of the Reverse Transcriptase (RT) region of pol gene. Results. Seventy three chronic HIV-1 infected ART naïve patients eligible for first line ART were enrolled from April 2006 to August 2008. In 68 patients DNA was successfully amplified and sequencing was done. 97% of HIV-1 strains belonged to subtype C, and one each to subtype A1 and subtype B. The overall prevalence of primary DRMs was 2.9% [2/68, 95% confidence interval (CI), 0.3%–10.2%]. One patient had a major RT mutation M184V, known to confer resistance to lamivudine, and another had a major protease inhibitor (PI) mutation D30N that imparts resistance to nelfinavir. Conclusion. Our study shows that primary HIVDR mutations have a prevalence of 2.9% among ART-naive chronic HIV-1 infected individuals.
format Article
id doaj-art-64c805cefbaa44de89ca6aadc9296c27
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-64c805cefbaa44de89ca6aadc9296c272025-02-03T05:59:27ZengWileyAIDS Research and Treatment2090-12402090-12592012-01-01201210.1155/2012/905823905823Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern IndiaS. Sinha0H. Ahmad1R. C. Shekhar2N. Kumar3L. Dar4J. C. Samantaray5S. K. Sharma6A. Bhargava7R. M. Pandey8R. L. Mitsuyasu9J. L. Fahey10Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaDepartment of Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, IndiaUCLA Center for Clinical AIDS Research and Education, University of California, Los Angeles, CA 90035, USADepartment of Medicine and Microbiology, University of California, Los Angeles, CA 90095, USAObjective. The increased use of antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV, adversely leading to the emergence of HIV drug resistance (HIVDR). In this study we aim to evaluate the prevalence of HIVDR mutations in ART-naive HIV-1 infected patients from northern India. Design. Analysis was performed using Viroseq genotyping system based on sequencing of entire protease and two-thirds of the Reverse Transcriptase (RT) region of pol gene. Results. Seventy three chronic HIV-1 infected ART naïve patients eligible for first line ART were enrolled from April 2006 to August 2008. In 68 patients DNA was successfully amplified and sequencing was done. 97% of HIV-1 strains belonged to subtype C, and one each to subtype A1 and subtype B. The overall prevalence of primary DRMs was 2.9% [2/68, 95% confidence interval (CI), 0.3%–10.2%]. One patient had a major RT mutation M184V, known to confer resistance to lamivudine, and another had a major protease inhibitor (PI) mutation D30N that imparts resistance to nelfinavir. Conclusion. Our study shows that primary HIVDR mutations have a prevalence of 2.9% among ART-naive chronic HIV-1 infected individuals.http://dx.doi.org/10.1155/2012/905823
spellingShingle S. Sinha
H. Ahmad
R. C. Shekhar
N. Kumar
L. Dar
J. C. Samantaray
S. K. Sharma
A. Bhargava
R. M. Pandey
R. L. Mitsuyasu
J. L. Fahey
Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
AIDS Research and Treatment
title Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
title_full Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
title_fullStr Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
title_full_unstemmed Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
title_short Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
title_sort prevalence of hiv drug resistance mutations in hiv type 1 isolates in antiretroviral therapy naive population from northern india
url http://dx.doi.org/10.1155/2012/905823
work_keys_str_mv AT ssinha prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT hahmad prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT rcshekhar prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT nkumar prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT ldar prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT jcsamantaray prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT sksharma prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT abhargava prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT rmpandey prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT rlmitsuyasu prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia
AT jlfahey prevalenceofhivdrugresistancemutationsinhivtype1isolatesinantiretroviraltherapynaivepopulationfromnorthernindia